| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/09/2006 | US7041642 Fluorescent bombesin-like peptides |
| 05/09/2006 | US7041641 Kit comprising osteogenic protein, matrix derived from nonsynthetic, nonpolymeric material, and binding agent for induction of local bone or cartilage formation |
| 05/09/2006 | US7041635 Factor VIII polypeptide |
| 05/09/2006 | US7041634 Method of inhibiting immune system destruction of transplanted viable cells |
| 05/09/2006 | US7041503 Modified myelin basic protein molecules |
| 05/09/2006 | US7041500 Insect cell line |
| 05/09/2006 | US7041499 Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth |
| 05/09/2006 | US7041498 Method for modulating processes mediated by farnesoid activated receptors |
| 05/09/2006 | US7041497 Used in regulation of genes for tissue inflammation, cellular proliferation, differentiation |
| 05/09/2006 | US7041496 Nucleotide sequences coding polypeptide for use in the treatment of ataxia, alzheimer's, parkinson's, learning defects, nervous system, epilepsy and stroke disorders |
| 05/09/2006 | US7041494 DNA encoding Slo2 and Slo4, potassium channel |
| 05/09/2006 | US7041491 NOD nucleic acids and polypeptides |
| 05/09/2006 | US7041489 Vaccines |
| 05/09/2006 | US7041478 Polypeptide for use in the treatment cancer, inflammation of autoimmune disorders |
| 05/09/2006 | US7041476 Nucleotide sequences coding polypeptide for use tools in genetic engineering |
| 05/09/2006 | US7041475 Transport protein for use in human therapeutics and diagnostics |
| 05/09/2006 | US7041474 Nucleic acid encoding human tango 509 |
| 05/09/2006 | US7041473 Alzheimer's disease secretase, APP substrates therefor, and uses thereof |
| 05/09/2006 | US7041467 Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement |
| 05/09/2006 | US7041463 Orthologues of human receptors and methods of use |
| 05/09/2006 | US7041462 analyzing a non-denatured protein by high pressure liquid chromatography; by using chimeric genes replacing a native signal sequence with a different signal sequence resulting in the production of a conformer, one can compare the native protein with the product of the chimeric gene |
| 05/09/2006 | US7041461 Nucleotide sequences coding membrame protein for use in analgesics |
| 05/09/2006 | US7041460 Antibodies to monocyte-colony inhibitory factor (M-CIF) |
| 05/09/2006 | US7041458 Methods and reagents for determining protein S |
| 05/09/2006 | US7041457 G-protein receptor for use in the detection of modulators of taste, odor and attraction |
| 05/09/2006 | US7041450 Method for diagnosing GH deficiency |
| 05/09/2006 | US7041448 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of genetic disorders associated with brain, vision and gastrointestinal disorders |
| 05/09/2006 | US7041446 Labeled protein and its producing method, labeling compound to be used in the method, and method for analyzing function of genes |
| 05/09/2006 | US7041444 Murine calicivirus |
| 05/09/2006 | US7041443 For therapy of porcine subject at risk of infection by, or displaying symptoms of, a porcine reproductive and respiratory syndrome virus infection |
| 05/09/2006 | US7041442 peptides or derivatives of the 65 kD lower matrix phoshpoprotein of HCMV useful for determining whether subjects have been exposed to the virus and for determining the peptide-induced production of interferon- gamma and/or TNF- alpha in CD8+ T cells isolated from subjects |
| 05/09/2006 | US7041440 IP3-binding polypeptides and methods of using them |
| 05/09/2006 | US7041437 Genes and methods for the screening of therapeutics useful for treating impaired glucose tolerance conditions, as well as diagnostics and therapeutic compositions for identifying or treating such conditions. |
| 05/09/2006 | US7041300 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 05/09/2006 | US7041299 vaccine against Newcastle Disease contains one or more mutant immunogens of the NDW strain that lack the antigenic binding site on the F glycoprotein which is recognized by the monoclonal antibody mAb 54. |
| 05/09/2006 | US7041298 Regulating protein activity with an ubiquitin pathway protein binding moiety coupled to a targeting moiety; used to perform target ubiquitination |
| 05/09/2006 | US7041295 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 05/09/2006 | US7041290 isolated monoclonal antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide of an epitope within or overlapping the amino acid sequence: SSDGLWNNNQTQLFLEHS; treating or preventing renal disease or injury |
| 05/09/2006 | US7041284 Recombinant adenoviral vector and method of use |
| 05/09/2006 | US7041282 Ligands for flt3 receptors |
| 05/09/2006 | US7041255 Detecting dengue virus in sample; obtain nucleotide sequences sample, incubate with primer, amplify, incubate with probe, detect signal, presence of signal indicates dengue virus |
| 05/09/2006 | CA2175687C A bacterial nitroreductase gene-prodrug system |
| 05/09/2006 | CA2093950C Subtilisin-like protease from aspergillus niger |
| 05/04/2006 | WO2006047744A2 Compositions of lactoferrin related peptides and uses thereof |
| 05/04/2006 | WO2006047728A2 Bmp gene and fusion protein |
| 05/04/2006 | WO2006047687A2 Compositions and methods for short interfering nucleic acid inhibition of nav1.8 |
| 05/04/2006 | WO2006047535A2 Melanocortin receptor binding mimetibodies, compositions, methods and uses |
| 05/04/2006 | WO2006047451A2 Immunoassays for lamotrigine |
| 05/04/2006 | WO2006047372A2 Lamotrigine analogs |
| 05/04/2006 | WO2006047367A2 Suppression of endogenous immunoglubolin expression in non-human transgenic animals |
| 05/04/2006 | WO2006047315A2 Targeted delivery of biological factors using self-assembling peptide nanofibers |
| 05/04/2006 | WO2006047311A2 Cloning of the retinoic acid inducible gene-1 promoter and uses thereof |
| 05/04/2006 | WO2006047298A2 Eph receptor tumor biomarkers |
| 05/04/2006 | WO2006047254A1 Assemblies of oligomeric amyloid beta protein and uses thereof |
| 05/04/2006 | WO2006047249A1 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 05/04/2006 | WO2006047172A1 Tweak receptor |
| 05/04/2006 | WO2006046963A2 Generation of virus-like particles and use as panfilovirus vaccine |
| 05/04/2006 | WO2006046957A1 Novel human gene with immunoregulatory and anti-proliferative properties |
| 05/04/2006 | WO2006046878A1 Production of fine particulates from keratin fibres |
| 05/04/2006 | WO2006046693A1 Method of assyaing htlv-i-specific t cell response |
| 05/04/2006 | WO2006046626A1 Water-soluble elastins, process for producing the same, and food and medicine containing the same |
| 05/04/2006 | WO2006046613A1 Il-18-like peptide, fused peptide thereof, method of producing the same and use of the same |
| 05/04/2006 | WO2006046455A1 Novel carbonyl reductase, gene therefor and use thereof |
| 05/04/2006 | WO2006046270A2 Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof |
| 05/04/2006 | WO2006046134A2 Method of screening by using conformation sensitive peptides |
| 05/04/2006 | WO2006046073A2 C1q related protein |
| 05/04/2006 | WO2006046072A2 VWFA AND/OR ANT_IG DOMAIN CONTAINING PROTEINS |
| 05/04/2006 | WO2006046017A2 Vaccine and nucleic acids capable of protecting poultry against colonisation by campylobacter |
| 05/04/2006 | WO2006045891A1 Avidin-like proteins from symbiotic bacteria |
| 05/04/2006 | WO2006045849A1 T-cadherin antigen arrays and uses thereof |
| 05/04/2006 | WO2006045677A1 Hcv vaccines for chronic hcv patients |
| 05/04/2006 | WO2006045503A1 Method for solid phase peptide synthesis |
| 05/04/2006 | WO2006045308A2 Chlamydia trachomatis antigens for vaccine and diagnostic use |
| 05/04/2006 | WO2006033014A3 Modulation of flowering time and growth cessation in perennial plants |
| 05/04/2006 | WO2006009809A3 Vegf inhibitors for the treatment of malignant pleural effusion |
| 05/04/2006 | WO2006008654A3 Rna dependent rna polymerases/primases from coronavirus and their use in molecular biology and drug screening |
| 05/04/2006 | WO2006004675A3 Production of tissue factor in plants |
| 05/04/2006 | WO2006003488A3 Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof |
| 05/04/2006 | WO2006000719A3 COG47 PROTEIN AND S100β GENE POLYMORPHISM |
| 05/04/2006 | WO2005123759A3 FGFR binding peptides |
| 05/04/2006 | WO2005121174A3 Novel g-csf polypeptides, polynucleotides, modulators thereof, and methods of use |
| 05/04/2006 | WO2005118628A3 Nucleic acid molecules encoding plant cyclotide polypeptides and methods of use |
| 05/04/2006 | WO2005116069A3 Taste receptors of the t1r family from domestic dog |
| 05/04/2006 | WO2005113606A3 Fgf-21 fusion proteins |
| 05/04/2006 | WO2005111068A3 A method for purifying and recovering silk proteins using magnetic affinity separation |
| 05/04/2006 | WO2005108416A3 Myosin light chain kinase inhibitors and their use |
| 05/04/2006 | WO2005106492A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3) |
| 05/04/2006 | WO2005103074A3 Combinatorial protein library screening by periplasmic expression |
| 05/04/2006 | WO2005100386A3 Canine cold-and menthol-sensitive receptor 1 |
| 05/04/2006 | WO2005084198A3 Peptides of il1 beta and tnf alpha and method of treatment using same |
| 05/04/2006 | WO2005056585A3 Sars coronavirus s proteins and uses thereof |
| 05/04/2006 | WO2005048944A3 Activatable photodynamic therapy agents |
| 05/04/2006 | WO2004074301A3 Differentially expressed nucleic acids that correlate with ksp expression |
| 05/04/2006 | WO2004037972A3 Endogenous retrovirus up-regulated in prostate cancer |
| 05/04/2006 | WO2004020595A3 Novel human polypeptides encoded by polynucleotides |
| 05/04/2006 | WO2004013311A3 Compositions and methods relating to ovarian specific genes and proteins |
| 05/04/2006 | WO2003097803A3 Cancer-linked gene as target for chemotherapy |
| 05/04/2006 | WO2003037264A3 Therapeutic anti-hiv (vpr) compounds |
| 05/04/2006 | WO2003020911A3 Human schizophrenia gene |
| 05/04/2006 | US20060095988 Synthetic plant genes and method for preparation |